The Biomaterials Market is expected to be around US$ 245.6 Billion by 2028 at a CAGR of 16% in the given forecast period.
The rising number of elderly populations, high incidence of cardiovascular, neurological, & orthopedic disorders, and increasing funding by government organizations to launch new products, rise in awareness regarding the benefits of biomaterials products, multiplying production of products, and advancements in medical technology are the significant drivers of the market. Furthermore, the porous-coated and fully or partially porous orthopedic implants have achieved significant popularity in recent years. This is owing to the superior property of the porous structures to reduce the elastic modulus and enhance bone growth around the implant. 3-D printing, powder metallurgy, and additive manufacturing are few potential techniques to manufacture porous metallic and ceramic implants. These factors are fueling the market at a global level.
The global Biomaterials market is segregated on the basis of Product as Natural Biomaterials, Metallic Biomaterials, Polymeric Biomaterials and Ceramic Biomaterials. Based on Application the global Biomaterials market is segmented in Cardiovascular, Dental, Orthopedic, Plastic Surgery, Wound Healing, Ophthalmology, Tissue Engineering, Neurology and Others.
The global Biomaterials market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biomaterials market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Royal DSM, BASF SE, Corbion N.V., Covestro, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, Berkeley Advanced Biomaterials, Inc, CAM Bioceramics BV, Celanese Corporation, Wright Medical Technology, Inc., Zimmer Biomet Holdings, Inc., Bayer AG, Collagen Matrix, and others are among the major players in the global Biomaterials market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biomaterials Market has been segmented as below:
Biomaterials Market, By Product
Biomaterials Market, By Application
Biomaterials Market, By Region
Biomaterials Market, By Company
The report covers:
Report Scope:
The global Biomaterials market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biomaterials market share. Major industry players with significant revenue share include Royal DSM, BASF SE, Corbion N.V., Covestro, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, Berkeley Advanced Biomaterials, Inc, CAM Bioceramics BV, Celanese Corporation, Wright Medical Technology, Inc., Zimmer Biomet Holdings, Inc., Bayer AG, Collagen Matrix, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Biological Seed Treatment Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. Biomaterials Market, By Product
5.1. Introduction
5.2. Natural Biomaterials
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Metallic Biomaterials
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Polymeric Biomaterials
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.5. Ceramic Biomaterials
5.5.1. Market Overview
5.5.2. Market Size and Forecast
6. Biomaterials Market, By Application
6.1. Introduction
6.2. Cardiovascular
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Dental
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Orthopedic
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Plastic Surgery
6.5.1. Market Overview
6.5.2. Market Size and Forecast
6.6. Wound Healing
6.6.1. Market Overview
6.6.2. Market Size and Forecast
6.7. Ophthalmology
6.7.1. Market Overview
6.7.2. Market Size and Forecast
6.8. Tissue Engineering
6.8.1. Market Overview
6.8.2. Market Size and Forecast
6.9. Neurology
6.9.1. Market Overview
6.9.2. Market Size and Forecast
6.10. Others
6.10.1. Market Overview
6.10.2. Market Size and Forecast
7. Biomaterials Market, By Geography
7.1. Introduction
7.2. North America
7.2.1. North America Biomaterials, By Product
7.2.2. North America Biomaterials, By Application
7.3. Europe
7.3.1. Europe Biomaterials, By Product
7.3.2. Europe Biomaterials, By Application
7.4. Asia-Pacific
7.4.1. Asia-Pacific Biomaterials, By Product
7.4.2. Asia-Pacific Biomaterials, By Application
7.5. Rest of the World
7.5.1. Rest of the World Biomaterials, By Product
7.5.2. Rest of the World Biomaterials, By Application
8. Competitive Insights
8.1. Key Insights
8.2. Company Market Share Analysis
8.3. Strategic Outlook
8.3.1. Mergers & Acquisitions
8.3.2. New Product Developments
8.3.3. Portfolio/Production Capacity Expansions
8.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5. Others
9. Company Profiles
9.1. Royal DSM
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. BASF SE
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Corbion N.V.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Covestro
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Invibio Ltd.
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Carpenter Technology Corporation
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Evonik Industries AG
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Berkeley Advanced Biomaterials, Inc.
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. CAM Bioceramics BV
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Celanese Corporation
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
9.11. Wright Medical Technology, Inc.
9.11.1. Company Overview
9.11.2. Product/Service Landscape
9.11.3. Financial Overview
9.11.4. Recent Developments
9.12. Zimmer Biomet Holdings, Inc.
9.12.1. Company Overview
9.12.2. Product/Service Landscape
9.12.3. Financial Overview
9.12.4. Recent Developments
9.13. Bayer AG
9.13.1. Company Overview
9.13.2. Product/Service Landscape
9.13.3. Financial Overview
9.13.4. Recent Developments
9.14. Collagen Matrix
9.14.1. Company Overview
9.14.2. Product/Service Landscape
9.14.3. Financial Overview
9.14.4. Recent Developments
The Biomaterials Market has been segmented as below:
Biomaterials Market, By Product
Biomaterials Market, By Application
Biomaterials Market, By Region
Biomaterials Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
